摘要
目的:观察芪明颗粒治疗2型糖尿病患者干眼症的临床疗效。方法:研究对象为临床确诊的2型糖尿病干眼症患者60例120只眼,其中30例接受芪明颗粒治疗(治疗组);另外30例接受常规治疗:采用爱丽滴眼液治疗(对照组),观察治疗前后患者泪液分泌量(Schirmer法)、泪膜破裂时间(BUT)及症状的变化。结果:治疗组总有效率78.33%(47/60),对照组46.67%(28/60),差异有统计学意义(P<0.05)。治疗后两组BUT及泪液分泌量比较,差异有统计学意义(P<0.05),治疗组优于对照组。结论:芪明颗粒对干眼治疗有着显著的疗效。
Objective：To observe the efficacy of Qiming Keli on xerophthalmia basing on non - insulin - dependent diabetes （NIDD）. Methods：the object of study was 60 patients （120 eyes）who were diagnosed as xerophthalmia with NIDD,30 patients were treated with Qiming Keli（treatment group） ,and the other 30 patients were treated with sodium hyaluronate treatment （ control group ）, Before and after treatment, tear secretion volume （ Schirmer＇ s test） , break - up time （BUT） and symptom were observed. Results： The total effective rate was 78.33% （47/60） in treatment group, and was 46. 67% （ 28/60 ） in control group, indicating significant statistical difference in comparison （ P 〈 0. 05 ）. There was a significant difference in statistics in tear secretion volume and BUT between two groups after treatment （ P 〈 0.05 ）. in which, the result in treatment group was superior to that in control group. Conclusion：Qiming Keli is significantly efficacious in treatment of xerophthalmia with NIDD.
